31482584|t|Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats.
31482584|a|We investigated whether clavulanic acid could improve learning and memory, in rats underwent bilateral occlusion of common carotid artery (2VO). Seventy male Wistar rats were subjected to 2VO, with a 1-week interval between right and left artery occlusions. After 2VO, animals received clavulanic acid (10, 20, 40 mg/kg, intraperitoneally), from day 8 to 20. Spatial memory was assessed in the Morris water maze, 1 week after the induction of 2VO (day 15). The mRNA expression levels of bcl-2, bcl2-associated x protein (bax), caspase-3, inducible nitric oxide synthase (iNOS), and amyloid beta precursor protein (APP) were measured in the neocortex and hippocampus. Clavulanic acid significantly decreased the escape latency and swimming time in the training trial days. As well, it increased time and distance percentage in the target quadrant, while it decreased such factors in the opposite quadrant in the final trial day, compared to 2VO + normal saline animals. Real time-PCR data showed a significant higher mRNA expression of bax, caspase 3, and iNOS in the hippocampus and neocortex of 2VO animal compared to nonoccluded rats. APP increased in the neocortex but not hippocampus. Compared with 2VO animals, clavulanic acid significantly down-regulated the expression of iNOS, caspase 3, and APP, accompanied by diminishing the bax/bcl2 ratio. Our results reveal a potential therapeutic use of clavulanic acid for cognitive dysfunction associated with cerebral hypoperfusion in vascular dementia and Alzheimer disease.
31482584	27	42	clavulanic acid	Chemical	MESH:D019818
31482584	73	104	common carotid artery occlusion	Disease	MESH:D002340
31482584	108	112	rats	Species	10116
31482584	138	153	clavulanic acid	Chemical	MESH:D019818
31482584	192	196	rats	Species	10116
31482584	217	251	occlusion of common carotid artery	Disease	MESH:D002340
31482584	253	256	2VO	Disease	
31482584	279	283	rats	Species	10116
31482584	302	305	2VO	Disease	
31482584	353	370	artery occlusions	Disease	MESH:D001157
31482584	378	381	2VO	Disease	
31482584	400	415	clavulanic acid	Chemical	MESH:D019818
31482584	557	560	2VO	Disease	
31482584	601	606	bcl-2	Gene	24224
31482584	608	633	bcl2-associated x protein	Gene	24887
31482584	635	638	bax	Gene	24887
31482584	641	650	caspase-3	Gene	25402
31482584	652	683	inducible nitric oxide synthase	Gene	24599
31482584	685	689	iNOS	Gene	24599
31482584	696	726	amyloid beta precursor protein	Gene	54226
31482584	781	796	Clavulanic acid	Chemical	MESH:D019818
31482584	1054	1057	2VO	Disease	
31482584	1149	1152	bax	Gene	24887
31482584	1154	1163	caspase 3	Gene	25402
31482584	1169	1173	iNOS	Gene	24599
31482584	1210	1213	2VO	Disease	
31482584	1245	1249	rats	Species	10116
31482584	1317	1320	2VO	Disease	
31482584	1330	1345	clavulanic acid	Chemical	MESH:D019818
31482584	1393	1397	iNOS	Gene	24599
31482584	1399	1408	caspase 3	Gene	25402
31482584	1450	1453	bax	Gene	24887
31482584	1454	1458	bcl2	Gene	24224
31482584	1516	1531	clavulanic acid	Chemical	MESH:D019818
31482584	1536	1557	cognitive dysfunction	Disease	MESH:D003072
31482584	1574	1596	cerebral hypoperfusion	Disease	MESH:D002547
31482584	1600	1617	vascular dementia	Disease	MESH:D015140
31482584	1622	1639	Alzheimer disease	Disease	MESH:D000544
31482584	Negative_Correlation	MESH:D019818	24599
31482584	Negative_Correlation	MESH:D019818	MESH:D015140
31482584	Negative_Correlation	MESH:D019818	24224
31482584	Negative_Correlation	MESH:D019818	MESH:D000544
31482584	Negative_Correlation	MESH:D019818	24887
31482584	Negative_Correlation	MESH:D019818	MESH:D002547
31482584	Negative_Correlation	MESH:D019818	MESH:D003072
31482584	Negative_Correlation	MESH:D019818	25402

